Sensei Biotherapeutics Inc Sustainability Reports
A clinical-stage biotechnology company that engages in the discovery and development of therapeutics for cancer patients, pioneering multi-node inhibition of the PAM pathway.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 8945002MP2CXKAENWU30
2 reports from 2022 to 2023